Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17042472 | 0.89 | HSP90AA1 (0.43) | HSP90AA1NUDT1BACE1THRB | |
| SCHEMBL17042266 | 0.89 | HSP90AA1 (0.43) | HSP90AA1NUDT1BACE1THRB | |
| SCHEMBL17042254 | 0.89 | HSP90AA1 (0.43) | HSP90AA1NUDT1BACE1THRB | |
| SCHEMBL17042274 | 0.87 | HSP90AA1 (0.41) | HSP90AA1NUDT1BACE1THRB | |
| SCHEMBL17042265 | 0.87 | HSP90AA1 (0.46) | HSP90AA1NUDT1BACE1THRBACMSD | |
| SCHEMBL30374852 | 0.82 | HSP90AA1 (0.49) | HSP90AA1NUDT1BACE1THRBACMSD | |
| SCHEMBL6759210 | 0.82 | HSP90AA1 (0.49) | HSP90AA1NUDT1BACE1THRBACMSD | |
| SCHEMBL17042532 | 0.82 | HSP90AA1 (0.44) | HSP90AA1NUDT1BACE1THRBACMSD | |
| SCHEMBL17042549 | 0.82 | HSP90AA1 (0.44) | HSP90AA1NUDT1BACE1THRBACMSD | |
| SCHEMBL31402587 | 0.82 | HSP90AA1 (0.44) | HSP90AA1NUDT1BACE1THRBACMSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025022769-A1 | CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT | 三菱瓦斯化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| WO-2025022768-A1 | CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT | 三菱瓦斯化学株式会社 | 2025-01-30 | — | — | WO | disclosed |
| EP-2913302-B1 | CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-9475761-B2 | Method for producing cyanogen-halide, cyanate ester compound and method for producing the same, and resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-10-25 | — | — | US | disclosed |
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-2913302-A1 | CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION | Mitsubishi Gas Chemical Company, Inc. (JP) | 2015-09-02 | — | — | EP | disclosed |
| EP-1336597-B1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL IND (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-6720460-B2 | FORMING HEAT RESISTANT, MECHANICAL STRENGTH POLYMER ADDITIVES; ACID CATALYZED REACTION OF ADAMANTANE DIOL OR TRIOL WITH PHENOLIC DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-04-13 | — | — | US | disclosed |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1336597-A1 | Hydroxyphenyl adamantanes and process for the production of the same | Honshu Chemical Industry Co., Ltd. (JP) | 2003-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299110-A1 | METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION | MB, CBR3, CRYAA | HSP90AA1 1227/4885NUDT1 1108/4885BACE1 3932/4885 |
| US-20030187307-A1 | Hydroxyphenyl adamantanes and process for the production of the same | CYP8B1, DHPS, P4HA1 | HSP90AA1 1741/4885NUDT1 312/4885BACE1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.